Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allele Biotechnology and Pharmaceuticals, Inc. v. Pfizer, Inc. et al
Case Number:
3:20-cv-01958
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 05, 2022
Pfizer, Allele Biotech End COVID Vax IP Fight
Allele Biotechnology and Pharmaceuticals Inc. has agreed to drop its suit in California federal court alleging that Pfizer and BioNTech poached research technology while testing their jointly produced COVID-19 vaccine.
-
May 05, 2021
Pfizer Loses Bid To Toss COVID-19 Vaccine IP Case
A California federal judge has refused to toss Allele Biotechnology and Pharmaceuticals Inc.'s suit claiming Pfizer and BioNTech poached research technology while testing their COVID-19 vaccine.
-
April 28, 2021
Pfizer Tells Court Allele Wrong On Hatch-Waxman Safe Harbor
Pfizer and BioNTech have urged a California federal judge to reject Allele's "doomsday warnings" that dismissing its infringement suit against them under the safe harbor provision of the Hatch-Waxman Act over its COVID-19 vaccine will destroy patent rights.
-
April 16, 2021
Allele Urges Court Not To Toss IP Suit Over Pfizer Vaccine
Allele Biotechnology and Pharmaceuticals Inc. warned Friday that letting Pfizer and BioNTech off the hook for allegedly poaching its research technology while testing their COVID-19 vaccine would "destroy established patent rights."
-
March 29, 2021
Pfizer, BioNTech Call IP Suit A 'Burden' On Vaccine Effort
Pfizer Inc. and BioNTech want a California federal judge to toss a suit claiming they used poached research technology in their testing of a COVID-19 vaccine, saying the case should be stopped before it "becomes another burden on" vaccine efforts.
-
February 09, 2021
Pfizer Says It's Immune From Vaccine Testing IP Claims
Pfizer Inc. and BioNTech urged a California federal judge Monday to toss a lawsuit accusing them of using poached technology in their testing of a COVID-19 vaccine, arguing that they're immune from patent infringement allegations when the accused actions are done in pursuit of FDA approval.
-
October 09, 2020
COVID-19 IP Catch-Up: Moderna Promises & Ed Sheeran
In this round of intellectual property updates tied to the COVID-19 pandemic, Moderna said it would hold off on enforcing certain patents and Ed Sheeran said getting to the U.S. for a copyright trial may be impossible, among many other litigation updates.
-
October 05, 2020
Pfizer, Regeneron Hit With Patent Suits Over COVID-19 Tech
Pfizer Inc. and Regeneron Pharmaceuticals Inc. were accused Monday of using poached technology in their development and testing of COVID-19 vaccines and treatments, according to a pair of patent infringement suits lodged in California and New York federal court.